Business Standard

Four or more dosage of HCQ helped health workers ward off Covid-19: ICMR

According to the National Task Force for Covid-19 in India recommended once a week maintenance dose for seven weeks (400 mg once weekly), following the loading dose (400 mg bd)

Hydroxychloroquine, coronavirus, covid-19, drug, drugs, pharma, pharmaceutical
Premium

However, the paper mentioned that simply initiating HCQ prophylaxis did not reduce the odds of acquiring Covid-19 infection among HCWs

ANI New Delhi
Citing noteworthy benefits of Hydroxychloroquine (HCQ) prophylaxis against coronavirus, the Indian Council of Medical Research (ICMR) has revealed that the consumption of four or more doses of the antimalarial drug- (HCQ), has shown a significant decline of Covid-19 infection among health care workers (HCWs).

As healthcare workers deputed in the treatment of coronavirus patients are at the higher risk of contracting virus, a pivotal study done by India's apex medical research body has revealed a significant reduction (>80 per cent) in the odds of Covid-19 infection in the HCWs was identified with the intake of six or more doses of HCQ

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in